Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine

Bibliography

• Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6
   PubMed Web of Science ®Google Scholar
• Sadiq TS, Gerber DA. Stem cells in modern medicine: reality or myth? J Surg Res 2004;122:280-91
   PubMed Web of Science ®Google Scholar
• Serakinci N, Keith WN. Therapeutic potential of adult stem cells. Eur J Cancer 2006;42:1243-6
   PubMed Web of Science ®Google Scholar
• Joo S, Ko IK, Atala A, et al. Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res 2012;35:271-80
   PubMed Web of Science ®Google Scholar
• Emanuel P. AFS cells – where do they fit on the continuum? The Hematologist: ASH News and Reports. 2007;4:1
   Google Scholar
• Klimanskaya I, Rosenthal N, Lanza R. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 2008;7:131-42
   PubMed Web of Science ®Google Scholar
• Hemberger M, Yang W, Natale D, et al. Stem cells from fetal membranes. A Workshop Report. Placenta 2008;22:S17-19
   Google Scholar
• Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009;4:423-33
   PubMed Web of Science ®Google Scholar
• Abdulrazzak H, Moschidou D, Jones G, et al. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface 2010;7:S689-706
   PubMed Web of Science ®Google Scholar
• Guillot PV, Gotherstrom C, Chan J, et al. Human first trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007;25:646-54
   PubMed Web of Science ®Google Scholar
• Roubelakis MG, Pappa KI, Bitsika V, et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007;16:931-51
   PubMed Web of Science ®Google Scholar
• Leschot NJ, Verjaal M, Treffers PE. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies. BJOG 1985;92:804-7
   Web of Science ®Google Scholar
• Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006;108:1067-72
   PubMed Web of Science ®Google Scholar
• De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotech 2007;25:100-6
   PubMed Web of Science ®Google Scholar
• Kim J, Lee Y, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007;40:75-90
   PubMed Web of Science ®Google Scholar
• Tsai MS, Lee JL, Chang YJ, et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004;19:1450-6
   PubMed Web of Science ®Google Scholar
• Tsai MS, Hwang SM, Tsai YL, et al. Clonal amniotic fluid-derived cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006;74:545-51
   PubMed Web of Science ®Google Scholar
• Bossolasco P, Montemurro T, Cova L, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 2006;16:329-36
   PubMed Web of Science ®Google Scholar
• Prusa AR, Marton E, Rosner M, et al. Oct-4 expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 2003;18:1489-93
   PubMed Web of Science ®Google Scholar
• Prusa AR, Marton E, Rosner M, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol 2004;191:309-14
   PubMed Web of Science ®Google Scholar
• Perin L, Sedrakyan S, Da Sacco S, et al. Characterization of human amniotic fluid stem cells and their pluripotential capacity. Methods Cell Biol 2008;86:85-99
   PubMed Web of Science ®Google Scholar
• Zhao P, Ise H, Hongo M, et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005;79:528-35
   PubMed Web of Science ®Google Scholar
• Kolambkar YM, Peister A, Soker S, et al. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 2007;38:405-13
   PubMed Web of Science ®Google Scholar
• Kunisaki SM, Armant M, Kao GS, et al. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 2007;42:974-80
   Google Scholar
• In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003;102:1548-9
   PubMed Web of Science ®Google Scholar
• Prusa AR, Hengstschläger M. Amniotic fluid cells and human stem cell research - a new connection. Med Sci Monit 2002;8:RA253-7
   PubMedGoogle Scholar
• Roubelakis MG, Bitsika V, Zagoura D, et al. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med 2011;15:1896-913
   PubMed Web of Science ®Google Scholar
• Klemmt PA, Vafaizadeh V, Groner B. The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expet Opin Biol Ther 2011;11:1297-314
   PubMed Web of Science ®Google Scholar
• Ditadi A, De Coppi P, Picone O, et al. Human and murine amniotic fluid c-Kit+Lin- cells display hematopoietic activity. Blood 2009;113:3953-60
   PubMed Web of Science ®Google Scholar
• Chen WQ, Siegel N, Li L, et al. Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25. J Proteome Res 2009;8:5285-95
   PubMed Web of Science ®Google Scholar
• Sessarego N, Parodi A, Podest`a M, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008;93:339-46
   PubMed Web of Science ®Google Scholar
• In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22:1338-45
   PubMed Web of Science ®Google Scholar
• Cipriani S, Bonini D, Marchina E, et al. Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain. Cell Biol Int 2007;31:845-50
   PubMed Web of Science ®Google Scholar
• Zagoura DS, Roubelakis MG, Bitsika V, et al. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut 2012;61:894-906
   PubMed Web of Science ®Google Scholar
• Delo DM, De Coppi P, Bartsch G, et al. Amniotic fluid and placental stem cells. Methods Enzymol 2006;419:426-38
   PubMed Web of Science ®Google Scholar
• Phermthai T, Odglun Y, Julavijitphong S, et al. A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol 2010;11:79
   PubMed Web of Science ®Google Scholar
• Bryan TM, Englezou A, Dunham MA, et al. Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res 1998;239:370-8
   PubMed Web of Science ®Google Scholar
• Miki T, Strom S. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev 2006;2:133-42
   PubMed Web of Science ®Google Scholar
• Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 2009;18:17-27
   PubMed Web of Science ®Google Scholar
• Da Sacco S, Sedrakyan S, Boldrin F, et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 2010;183:1193-200
   PubMed Web of Science ®Google Scholar
• Kaviani A, Perry TE, Dzakovic A, et al. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 2001;36:1662-5
   PubMed Web of Science ®Google Scholar
• In't Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88:845-52
   PubMed Web of Science ®Google Scholar
• Nadri S, Soleimani M. Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy 2007;9:729-37
   PubMed Web of Science ®Google Scholar
• Tsai M, Hwang SM, Chen KD, et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007;25:2511-23
   PubMed Web of Science ®Google Scholar
• Chambers I, Silva J, Colby D, et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007;450:1230-4
   PubMed Web of Science ®Google Scholar
• Valli A, Rosner M, Fuchs C, et al. Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene 2010;29:966-77
   Google Scholar
• Atala A. Amniotic fluid-derived pluripotential cells. In: Lanza R, editor. Essentials of stem cell biology. Chapter 16. Academic Press, USA; 2009. p. 145-50
   Google Scholar
• Carraro G, Perin L, Sedrakyan S, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008;26:2902-11
   PubMed Web of Science ®Google Scholar
• Bajek A, Olkowska J, Drewa T. Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration. Postepy Hig Med Dosw 2011;65:124-32
   Web of Science ®Google Scholar
• Gimble JM, Guilak F, Nuttall ME, et al. In vitro differentiation potential of mesenchymal stem cells. Transfus Med Hemother 2008;35:228-38
   PubMed Web of Science ®Google Scholar
• Atala A. Engineering organs. Curr Opin Biotechnol 2009;20:575-92
   PubMed Web of Science ®Google Scholar
• Langer R, Vacanti JP. Artificial organs. Sci Am 1995;273:130-3
   PubMed Web of Science ®Google Scholar
• Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999;354:SI32-4
   PubMed Web of Science ®Google Scholar
• Schmidt D, Achermann J, Odermatt B, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007;116:164-70
   Google Scholar
• Schmidt D, Achermann J, Odermatt B, et al. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis 2008;17:446-55
   PubMed Web of Science ®Google Scholar
• Antonucci I, Pantalone A, De Amicis D, et al. Human amniotic fluid stem cells culture onto titanium screws: a new perspective for bone engineering. J Biol Regul Homeost Agents 2009;23:277-9
   PubMed Web of Science ®Google Scholar
• Chiavegato A, Bollini S, Pozzobon M, et al. Human amniotic fluid-derived stem cells are rejected after transplantation in myocardium of normal, ischemic, immunosuppressed or immune-deficient rat. J Mol Cell Cardiol 2007;42:746-59
   PubMed Web of Science ®Google Scholar
• Yeh YC, Wei HJ, Lee WY, et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A 2010;16:1925-36
   PubMed Web of Science ®Google Scholar
• Yeh YC, Lee WY, Yu CL, et al. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials 2010;31:6444-53
   Google Scholar
• Lee WY, Wei HJ, Lin WW, et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem cell bodies enriched with endogenous ECM. Biomaterials 2011;32:5558-67
   PubMed Web of Science ®Google Scholar
• Gekas J, Walther G, Skuk D, et al. In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage. Clin Exp Med 2010;10:1-6
   Google Scholar
• Ma X, Zhang S, Zhou J, et al. Clone-derived human AF-amniotic fluid stem cells are capable of skeletal myogenic differentiation in vitro and in vivo. J Tissue Eng Regen Med 2012;6:598-613
   PubMed Web of Science ®Google Scholar
• Piccoli M, Franzin C, Bertin E, et al. Amniotic fluid stem cells restore the muscle cell niche in a HAS-Cre, Smn(F7/F7) mouse model. Stem Cells 2012;30:1675-84
   PubMed Web of Science ®Google Scholar
• Peister A, Deutsch ER, Kolambkar Y, et al. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A 2009;15:3129-38
   Google Scholar
• Rodrigues MT, Lee BK, Lee SJ, et al. The effect of differentiation stage of amniotic fluid stem cells on bone regeneration. Biomaterials 2012;33:6069-78
   PubMed Web of Science ®Google Scholar
• Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007;40:936-48
   PubMed Web of Science ®Google Scholar
• Pan HC, Yang DY, Ho SP, et al. Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto. J Biomed Sci 2009;16:75
   PubMed Web of Science ®Google Scholar
• Galderisi U, Helmbold H, Squillaro T, et al. In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes. Stem Cells Dev 2009;18:1033-41
   Google Scholar
• Perin L, Sedrakyan S, Giuliani S, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS ONE 2010;5:e9357
   PubMed Web of Science ®Google Scholar
• Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 2006;44:215-30
   PubMed Web of Science ®Google Scholar
• Price FD, Kuroda K, Rudnicki MA. Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 2007;1772:272-83
   PubMed Web of Science ®Google Scholar
• Bongso A, Fong CY, Gauthaman K. Taking stem cells to the clinic: major challenges. J Cell Biochem 2008;105:1352-60
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Kucia M, Ratajczak J, et al. A multi-instrumental approach to identify and purify very small embryonic like stem cells (VSELs) from adult tissues. Micron 2009;40:386-93
   PubMed Web of Science ®Google Scholar
• Choumerianou DM, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev 2008;14:53-60
   PubMed Web of Science ®Google Scholar
• Liu ZS, Xu YF, Feng SW, et al. Baculovirus-transduced mouse amniotic fluid-derived stem cells maintain differentiation potential. Ann Hematol 2009;88:565-72
   PubMed Web of Science ®Google Scholar
• Guillot PV, O'Donoghue K, Kurata H, et al. Fetal stem cells: betwixt and between. Semin Reprod Med 2006;24:340-7
   PubMed Web of Science ®Google Scholar
• Guillot PV, Cui W, Fisk NM, et al. Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med 2007;11:935-44
   PubMed Web of Science ®Google Scholar
• Li C, Zhou J, Shi G, et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 2009;18:4340-9
   PubMed Web of Science ®Google Scholar
• Horwitz EM. Stem cell plasticity: the growing potential of cellular therapy. Arch Med Res 2003;34:600-6
   PubMed Web of Science ®Google Scholar
• Morange M. How phenotypic plasticity made its way into molecular biology. J Biosci 2009;34:495-501
   PubMed Web of Science ®Google Scholar
• De Coppi P, Callegari A, Chiavegato A, et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 2007;177:369-76
   PubMed Web of Science ®Google Scholar